-
2024-515998-94-00
5
2022-11-10
We investigate the efficacy of two pharmaceutical interventions for re
-
2023-504885-50-00
5
2022-11-07
Treatment of children with chronic kidney disease and proteinuria
-
2023-504264-41-00
9
2022-11-04
CD20 positive B-Cell Non-Hodgkin Lymphoma (NHL)
-
2024-515174-27-00
4
2022-10-03
Acute Lymphoblastic Leukemia and B-cell Non Hodgkin Lymphoma
-
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
-
2023-507557-16-00
5
2022-08-31
chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
-
2022-500125-32-00
6
2022-06-20
Myocardial infarction
-
2023-505512-37-00
5
2022-06-07
Acute Myeoloid Leukemia
-
2024-513168-24-00
4
2022-06-01
HIV & Obesity
-
2024-513412-10-00
9
2022-05-11
Anaplastic Large Cell Lymphoma (ALCL)
-
2024-516131-28-00
4
2022-04-18
Breast cancer, neuroendocrine neoplasms, lymphomas, sarcomas
-
2024-514590-22-00
7
2022-03-10
Subarachnoid haemorrhage – SAH
-
2022-502434-10-00
4
2022-02-22
Cutaneous T-cell lymphoma, a category of cancers of lymphocytes (a
typ
-
2024-516318-40-02
4
2022-02-21
Esophageal Cancer
-
2024-515160-32-00
4
2022-02-02
Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
-
2023-508963-58-00
4
2022-01-31
Symptomatic hypertrophic cardiomyopathy (HCM)
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-518436-37-01
4
2021-12-01
Myelodysplastic syndromes (MDS), very low- and low-risk
-
2023-504152-97-00
5
2021-11-26
Generalized Myasthenia Gravis
-
2023-508105-24-00
5
2021-11-11
COVID-19
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2023-505163-37-00
3
2021-10-01
Metastatic Colorectal Cancer
-
2024-510691-20-00
4
2021-09-23
RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced So
-
2023-509814-12-00
4
2021-09-22
Colorectal cancer with metastasis